DOI QR코드

DOI QR Code

Quantitative Analysis of Paeoniflorin and Paeonol in Peony Extracts and Quality Control Standards

모란 추출액에서 paeoniflorin과 paeonol 동시 정량 분석 및 화장품 원료의 품질관리 기준 설정

  • Yun, Ki-Hun (Department of Industrial Engineering Chemistry, Chungbuk National University) ;
  • Chi, Yong-Ha (Research Institute, Soleon, Co. Ltd) ;
  • Lee, Dong-Kyu (Department of Industrial Engineering Chemistry, Chungbuk National University) ;
  • Paik, Soo-Heui (Department of Pharmacy, Sunchon National University)
  • 윤기훈 (충북대학교 공과대학 공업화학과) ;
  • 지용하 ((주)솔레온 기업부설연구소) ;
  • 이동규 (충북대학교 공과대학 공업화학과) ;
  • 백수희 (순천대학교 약학대학 약학과)
  • Received : 2018.02.21
  • Accepted : 2018.03.21
  • Published : 2018.03.30

Abstract

Paeony has pharmacological activities such as anti-inflammatory, anti-allergic, anti-bacterial, central inhibitory, gastric secretion inhibition, and antispasmodic activities. In addition, its antioxidant activity and whitening effect being reported, thus it is being explored as raw materials for cosmetics. We compared the changes in the contents of paeoniflorin and paeonol in Peony extracts, depending on the changes of extracting solvents, temperature and time. The HPLC method was set up for simultaneous analysis, the system suitabilities were confirmed by using the calibration curves and the QC samples for each assay batch. Paeonol was detected only in roots, and paeoniflorin was higher in leaf and flower than root. Higher concentrations of both ingredients were extracted when the root was used after grinding to a suitable size, and when 30% 1,3-butylene glycol was used as the extraction solvent. Also the concentrations tended to increase at higher temperature and longer time, but the increase was gradual at over $75^{\circ}C$ and 4 hours. The ratio of root, leaf and flower was determined to be 2+2+1g/0.5kg of batch, reaching the contents criteria of paeoniflorin and paeonol. Finally, we selected as the best extraction condition when the raw materials are mixed with 2+2+1g/0.5kg and extracted with 30% 1,3-butylene glycol as an extraction solvent at $75^{\circ}C$ for 4 hours, considering both the concentrations of two components and the cost of raw materials and manufacturing process, The extraction units were scaled up to 10 kg under this condition.

모란은 항염증작용, 항알레르기작용, 항균작용, 중추억제, 위액분비억제, 진경작용 등의 약리활성이 있을 뿐 아니라 항산화작용, 미백작용 등이 보고되면서 화장품 원료, 미용식품으로 다양하게 활용 가능성이 탐색되고 있다. 모란의 뿌리, 잎 및 꽃에서 추출용매와 온도, 시간에 따른 추출액 중 성분의 함량 변화를 비교하였다. Paeoniflorin과 paeonol을 지표성분으로 하여 두 성분의 함량을 동시에 정량분석하기 위한 HPLC 분석법을 설정하고 분석 배치마다 검량선과 QC용 검체를 사용하여 시스템적합성을 확인하면서 시료 분석을 실시하였다. Paeonol은 뿌리에서만 검출되었고 잎과 꽃에서는 검출되지 않았으며, paeoniflorin은 잎, 꽃에서의 농도가 뿌리에서보다 높았다. 추출용매와 섞을 때 뿌리의 절도는 구입 당시의 조각을 그대로 사용할 때보다 적당한 크기로 분쇄한 후 사용할 때 두 성분 모두 높은 농도로 추출되었다. 추출용매로는 30% 1,3-butylene glycol을 사용할 때 농도가 가장 높았다. 추출온도와 시간은 고온, 장시간 일수록 농도가 높아지는 경향을 보였으나 $75^{\circ}C$, 4 h 이상에서는 농도 상승이 완만했으며, paeonol은 8 h까지 지속적으로 농도가 상승하는 경향을 보였다. 뿌리, 잎, 꽃의 배합 비율은 2+2+1g/0.5kg로 할 때 두 지표성분의 함량 기준에 도달 가능하다고 판단하였다. 최종적으로 원재료를 2+2+1g/0.5kg로 배합하고 30% 1,3-butylene glycol을 추출용매로 사용하여 $75^{\circ}C$에서 4 h 동안 추출하는 방법이 두 지표성분의 활성 농도 기준과 원재료 및 제조공정상의 비용을 함께 고려할 때 적절한 조건이라고 판단하였고, 이 조건에서 10 kg 규모까지 추출액 제조 단위를 스케일업 하였다.

Keywords

References

  1. Global Market Report, "Natural Cosmetics Market Trends in Major Countries," pp. 15-032, KOTRA, (2015).
  2. Natural Cosmetics Industry Trend Report, The Foundation of AG. Tech, Commercialization and Transfer, (2013).
  3. R. S. Sung, "Quality Control Study of Oriental (herbal) Medicines Using Ingredient Profile(I)," Ministry of Food and Drug Safety, (2015).
  4. R. S. Sung, "Agastachis Herba(KHP). Etc. Study on the 7 Contents Standard Setting," Final Report of Research and development task, Ministry of Food and Drug Safety, (2015).
  5. K. Choi, Fei Zhao, J. W. Choi, Y. H. Kwon, "Changes of Paeonol and Paeoniflorin Contents in Chinese Moutan (Paeonia suffruticosa Andrews) Cultivars with Different Harvesting Times and Their Parts," Korea J. Medicinal Crop Sci. Vol. 13, No. 1, pp. 35-40, (2005).
  6. C. S. Seo, J. H. Kim, H. K. Shin, B. S. Kim, “Quantitative Analysis of (+)-Catechin, Paeoniflorin, and Paeonol in Moutan Radicis Cortex and Its Processed Products,” Kor. J. Pharmacogn., Vol. 47, No. 3, pp. 237-245, (2016).
  7. B. Wang, Z. Pang, Q. Zhang, “Chemiluminescence in the Study of Paeonol,” Chimese Pharmaceutical Journal, Vol. 29, No. 1, pp. 35-38, (1994).
  8. J. Yu, H. Lang, P. Xia, "The Occurrence of Paeoniflorins and Paeonols in Paeoniaceae," ACTA Pharmaceutica Sinica, No. 20, pp. 229-234, (1985).
  9. The Korean Pharmacopoeia Eleventh Edition, Ministry of Food and Drug Safety, (2013).
  10. "Test method of Herbal medicine," The Korean Pharmacopoeia etc. oriental (herbal) medicines codex, VI, (2014).
  11. M. Y. Kim and K. S. Ko, “Study on Cosmeceutical Activities of Moutan Cortex Radicis Extracts,” Journal of the Korean Society of Cosmetology, Vol. 19, No. 6, pp. 1119-1126, (2013).
  12. S. J. Hur, K. Y. Kim, E. Y. Park, A. R. Jang, K. S. Yang, W. K. Whang, “Antioxidation Activity and Inhibition of B16F10 Melanoma Cell from Moutan Cortex from Ethanol Extracts,” Journal of the Korean Society for Aesthetics and Cosmetology, Vol. 8, No. 1, pp. 1-9, 2010).
  13. J. K. You, M. J. Chung, D. J. Kim, D. J. Seo, J. H. Park, T. W. Kim, M. Choe, “Antioxidant and Tyrosinase Inhibitory Effects of Paeonia suffruticosa Water Extract,” J Korean Soc Food Sci Nutr, Vol. 38, No. 3, pp. 292-296, (2009). https://doi.org/10.3746/jkfn.2009.38.3.292
  14. Y. G. Kim, G. Y. Lee, Y. W. Cho, M. A. Lee, S. W. Baek, S. H. Sung, C. J. Ma, E. J. Jung, S. H. Kim, E. S. Yang, Y. K. Cho, S. H. Kim, J. H. Park, E. J. Choi, M. J. Lee, E. J. Lee, Report on "KNTP Acquisition and Analysis of Raw Materials for Toxicity Test," Ministry of Food and Drug Safety, (2008).
  15. G. H. Bae, Report on "Isolation and Quantitative Analysis of Bioactive Compounds from Cinnamoni Ramulus and Moutan Root Bark," Ministry of Food and Drug Safety, (2007).
  16. Y. Ding, E. Wu, J. Chen, H. T. Nguyen, T. H. Do, K. L. Park, K. H. Bae, Y. H. Kim,. J. S. Kang, “Quality Evaluation of Moutan Cortex Radicis using Multiple Component Analysis by High Performance Liquid Chromatography,” Bull. Korean Chem. Soc, Vol. 30, No. 10, pp. 2240-2244, (2009). https://doi.org/10.5012/bkcs.2009.30.10.2240
  17. Y. Xie, Z. H. Jiang, H. Zhou, W. Z. Ma, Y. F. Wong, Z. Q. Liu, L. Liu, "The Pharmacokinetic Study of Sinomenine, Paeoniflorin and Paeonol in Rats after Oral Administration of a Herbal Product Qingfu Guanjiesu Capsule by HPLC," Biomed. Chromatogr, No. 28, pp. 1294-1302, (2014). https://doi.org/10.1002/bmc.3165
  18. Y. W. Son. Guidelines for Validation of Test Methods such as Medicines, Ministry of Food and Drug Safety, (2015).
  19. Y. S. Park, M. H. Oh, H. Lee, J. T. Jung, Y. H. Jo, M. K. Pyo, "Comparison of Malonyl Ginsenoside Contents in Parts of Korean Ginseng," Kor. J. Pharmacogn. Vol. 48, No. 1, pp. 82-87, (2017).
  20. B. R. Jeong, Y. S Yoon, S. S. Shin, Y. S. Kwon, H. J. Yang, “Simultaneous Determination of (+)-Pseudoephedrine and (-)-Ephedrine in Ephedra Intermedia by HPLC-UV,” Kor. J. Pharmacogn, Vol. 48, No. 1, pp. 93-96, (2017).